PHARMACOKINETICS
Clinical trials for PHARMACOKINETICS explained in plain language.
Never miss a new study
Get alerted when new PHARMACOKINETICS trials appear
Sign up with your email to follow new studies for PHARMACOKINETICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental pill called IPG7236 in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink or control the cancer. About 196 adults will take the pill twice…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New inhaled drug RCS-21 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage trial is checking if a single inhaled dose of RCS-21 is safe and tolerable in 24 healthy adults aged 18 to 64. Participants receive one dose and are closely monitored for side effects. The study does not aim to treat any disease, just to gather initial safety and…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: RNATICS GmbH • Aim: Knowledge-focused
Last updated May 17, 2026 05:27 UTC
-
Healthy volunteers needed to test two versions of heart drug
Knowledge-focused Recruiting nowThis study tests how the body handles two different forms of evolocumab, a drug used to lower cholesterol. About 400 healthy adults aged 18 to 60 will receive a single dose and be monitored for drug levels and side effects. The goal is to compare the two versions, not to treat an…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Amgen • Aim: Knowledge-focused
Last updated May 17, 2026 05:27 UTC
-
Healthy volunteers test new tamper-resistant painkiller combo
Knowledge-focused Recruiting nowThis early-stage study tests how a new painkiller (PF614) moves through the body when taken alone or with another drug (nafamostat). Thirty healthy adults aged 18 to 55 will receive a single dose, and researchers will measure drug levels in the blood over time. The goal is to und…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Ensysce Biosciences • Aim: Knowledge-focused
Last updated May 17, 2026 05:08 UTC
-
Are we giving kids the right antibiotic dose? new study investigates
Knowledge-focused Recruiting nowThis study looks at whether antibiotics given to critically ill children in the ICU reach the right levels in their blood to fight infections effectively. Researchers will measure drug concentrations after the first dose and at steady state in 640 children from newborns to age 15…
Matched conditions: PHARMACOKINETICS
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated May 17, 2026 05:07 UTC
-
Cannabis study: what happens when you stop smoking?
Knowledge-focused Recruiting nowThis study looks at how smoking high-potency cannabis affects pain relief and feelings of being high. Researchers will test 30 near-daily cannabis users who are not trying to quit. They will compare results when people smoke as usual and after a short break from cannabis.
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
New antibiotic combo tested in healthy volunteers – no cure yet
Knowledge-focused Recruiting nowThis early-stage study tests a new antibiotic combination (ceftibuten-ledaborbactam etzadroxil) in about 46 healthy adults aged 18-55. The goal is to check safety and how the drug moves through the body, not to treat any disease. Results will help decide if further studies are po…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Study aims to perfect antibiotic dosing for kids on ECMO
Knowledge-focused Recruiting nowThis study looks at how antibiotics work in critically ill newborns, infants, and children who are on a life-support machine called ECMO. The goal is to see if current antibiotic doses are effective and safe. Researchers will measure drug levels in the blood to find the best dosi…
Matched conditions: PHARMACOKINETICS
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC
-
New study tracks antifungal drug in critically ill kids
Knowledge-focused Recruiting nowThis study looks at how the antifungal medicine caspofungin behaves in children with severe infections, especially those with liver problems or on life support like ECMO. Researchers will measure drug levels in the blood to understand dosing better. The goal is to improve treatme…
Matched conditions: PHARMACOKINETICS
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated May 04, 2026 16:19 UTC